NEUROPACE, INC. Operating Lease Right-of-Use Assets
NEUROPACE, INC. (NPCE) had Operating Lease Right-of-Use Assets of $9.22 million as of 2026-06-30, per its 10-Q filed 2026-08-11.
Financial Statements › Balance Sheet › Assets › Assets, Noncurrent
us-gaap:OperatingLeaseRightOfUseAsset · last filed 2026-08-11
- 2026-06-30: Operating Lease, Right-of-Use Asset $9.22M.
- 2026-03-31: Operating Lease, Right-of-Use Asset $9.68M.
- 2025-12-31: Operating Lease, Right-of-Use Asset $10.13M.
- 2025-09-30: Operating Lease, Right-of-Use Asset $10.57M.
| Period end | Operating Lease, Right-of-Use Asset |
|---|---|
| 2026-06-30 | $9.22M 10-Q · filed 2026-08-11 |
| 2026-03-31 | $9.68M 10-Q · filed 2026-05-12 |
| 2025-12-31 | $10.13M 10-Q · filed 2026-08-11 |
| 2025-09-30 | $10.57M 10-Q · filed 2025-11-04 |
| 2025-06-30 | $11.01M 10-Q · filed 2025-08-12 |
| 2025-03-31 | $11.43M 10-Q · filed 2025-05-13 |
| 2024-12-31 | $11.84M 10-K · filed 2026-03-03 |
| 2024-09-30 | $12.25M 10-Q · filed 2024-11-12 |
| 2024-06-30 | $12.64M 10-Q · filed 2024-08-13 |
| 2024-03-31 | $13.03M 10-Q · filed 2024-05-08 |
| 2023-12-31 | $13.40M 10-K · filed 2025-03-04 |
| 2023-09-30 | $13.77M 10-Q · filed 2023-11-06 |
| 2023-06-30 | $14.14M 10-Q · filed 2023-08-08 |
| 2023-03-31 | $14.49M 10-Q · filed 2023-05-04 |
| 2022-12-31 | $14.84M 10-K · filed 2024-03-05 |
| 2022-09-30 | $15.07M 10-Q · filed 2022-11-08 |
| 2022-06-30 | $4.99M 10-Q · filed 2022-08-11 |
| 2022-03-31 | $5.56M 10-Q · filed 2022-05-12 |
| 2022-01-01 | $6.10M 10-K · filed 2023-03-02 |
| 2021-12-31 | $0.00 10-K · filed 2023-03-02 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Sight Sciences, Inc. (SGHT) | United States | $0.478B | -9.95 |
| ClearPoint Neuro, Inc. (CLPT) | United States | $0.446B | -15.74 |
| TACTILE SYSTEMS TECHNOLOGY INC (TCMD) | United States | $0.519B | 27.16 |
| CERUS CORP (CERS) | United States | $0.525B | -86.40 |
| CARLSMED, INC. (CARL) | United States | $0.405B | |
| DELCATH SYSTEMS, INC. (DCTH) | United States | $0.558B | 820.33 |
| Orthofix Medical Inc. (OFIX) | $0.373B | ||
| SS Innovations International, Inc. (SSII) | $0.589B | -64.06 | |
| ORTHOPEDIATRICS CORP (KIDS) | United States | $0.592B | |
| Orchestra BioMed Holdings, Inc. (OBIO) | United States | $0.356B | -4.39 |